Share
Market Research Report

AGE-RELATED MACULAR DEGENERATION THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Therapeutic TypeAnti-VEGF Drugs · Photodynamic Therapy · Corticosteroids · Nutritional Supplements · Others
  • By Distribution ChannelHospital Pharmacy · Retail Pharmacy · Online Pharmacy · Others
  • By ApplicationDry AMD · Wet AMD · Mixed Type · Others
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East & Africa
  • Published In27 Mar 2026
  • Report CodeCMI786
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033

Table of Contents

  1. Research Objectives and Assumptions

    1. Research Objectives

    2. Assumptions

    3. Abbreviations

  2. Market Preview

    1. Report Description

      1. Market Definition and Scope

    2. Executive Summary

      1. Market Snapshot, By Therapeutic Type

      2. Market Snapshot, By Distribution Channel

      3. Market Snapshot, By Application

      4. Market Snapshot, By Region

    3. Coherent Opportunity Map (COM)

  3. Market Dynamics, Regulations, and Trends Analysis

    1. Market Dynamics

      1. Drivers

      2. Restraints

      3. Market Opportunities

    2. Impact Analysis

    3. Recent Product Launches

    4. Epidemiology

    5. Merger, Acquisition, and Collaboration

    6. Regulatory Scenario

    7. Key Developments

    8. PEST Analysis

    9. Partnership Scenario

    10. Brand and Pricing Analysis

    11. Distributors Landscape

    12. Porters Analysis

    13. Technological Advancements

    14. Key Developments

    15. Market Trend

    16. Future Prospective

    17. Top Market Players by Revenue

  4. Age-Related Macular Degeneration Therapeutics Market By Therapeutic Type, 2026–2033, (US$ Billion)

    1. Introduction

      1. Market Share Analysis, 2026 and 2033 (%)

      2. Y-o-Y Growth Analysis, 2022–2033

      3. Segment Trends

    2. Anti-VEGF Drugs

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    3. Photodynamic Therapy

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    4. Corticosteroids

      1. Introduction 

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    5. Nutritional Supplements

      1. Introduction 

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    6. Others

      1. Introduction 

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)

  5. Age-Related Macular Degeneration Therapeutics Market By Distribution Channel, 2026-2033, (US$ Billion)

    1. Introduction

      1. Market Share Analysis, 2026 and 2033 (%)

      2. Y-o-Y Growth Analysis, 2022–2033

      3. Segment Trends

    2. Hospital Pharmacy

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    3. Retail Pharmacy

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    4. Online Pharmacy

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    5. Others

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

  6. Age-Related Macular Degeneration Therapeutics Market By Application, 2026-2033, (US$ Billion)

    1. Introduction

      1. Market Share Analysis, 2026 and 2033 (%)

      2. Y-o-Y Growth Analysis, 2022–2033

      3. Segment Trends

    2. Dry AMD

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    3. Wet AMD

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    4. Mixed Type

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    5. Others

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

  7. Age-Related Macular Degeneration Therapeutics Market By Region, 2026-2033, (US$ Billion)

    1. Introduction

      1. Market Share Analysis, By Region, 2026 and 2033 (%)

      2. Y-o-Y Growth Analysis, For Regions, 2022–2033

      3. Regional Trends

    2. North America

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Type, 2026-2033, (US$ Billion)

      3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (US$ Billion)

      4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (US$ Billion)

      5. Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

        1. U.S.

        2. Canada

    3. Latin America

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Type, 2026-2033, (US$ Billion)

      3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (US$ Billion)

      4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (US$ Billion)

      5. Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

        1. Brazil

        2. Mexico

        3. Argentina

        4. Rest of Latin America

    4. Europe

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Type, 2026-2033, (US$ Billion)

      3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (US$ Billion)

      4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (US$ Billion)

      5. Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

        1. U.K.

        2. Germany

        3. Italy

        4. France

        5. Spain

        6. Russia

        7. Benelux

        8. Denmark

        9. Norway

        10. Sweden

        11. Rest of Europe

    5. Asia Pacific

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Type, 2026-2033, (US$ Billion)

      3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (US$ Billion)

      4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (US$ Billion)

      5. Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

        1. China

        2. Taiwan

        3. India

        4. Japan

        5. Indonesia

        6. Malaysia

        7. Philippines

        8. Singapore

        9. Australia

        10. South Korea

        11. Rest of Asia Pacific

o    Middle East & Africa

  1. Introduction

  2. Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Type, 2026-2033, (US$ Billion)

  3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (US$ Billion)

  4. Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (US$ Billion)

  5. Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

    1. Bahrain

    2. Kuwait

    3. Oman

    4. Qatar

    5. Saudi Arabia

    6. UAE

    7. Israel

    8. South Africa

    9. North Africa

    10. Central Africa

    11. Rest of the Middle East

  1. Competitive Landscape

    • Novartis AG

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Bayer AG

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Roche Holdings AG

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Alcon Inc.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Allergan plc

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Genentech Inc.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Apellis Pharmaceuticals

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Iveric Bio

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

  1. Section

    • Research Methodology

    • About Us